670 670 (Diltiazem Extended Release 180 mg)
Pill imprint 670 670 has been identified as Diltiazem hydrochloride extended release 180 mg.
Diltiazem is used in the treatment of atrial fibrillation; high blood pressure; supraventricular tachycardia; heart failure; atrial flutter (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 180 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 670 670 (Diltiazem Extended Release 180 mg)
- Imprint:
-
670
670 - Strength:
- 180 mg
- Color:
- Green & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
Group IV antiarrhythmics - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 47335-0670
- Inactive Ingredients:
- hypromellose 2910 (5 mPa.s)
magnesium silicate
ethylcelluloses
triethyl citrate
gelatin
titanium dioxide
sodium lauryl sulfate
FD&C Blue No. 1
FD&C Green No. 3
D&C Yellow No. 10
More resources
Diltiazem hydrochloride extended release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
